Skip to main content
TipRanks
Go Ultimate75% OFF

Arch Biopartners (ACHFF) Financial Statements

0 Followers

Arch Biopartners Financial Overview

Arch Biopartners's market cap is currently C$44.26M. The company's EPS TTM is C$-0.04; its P/E ratio is -21.88; Arch Biopartners has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 2.12MC$ 1.98MC$ 964.68KC$ 3.89M
Gross ProfitC$ 0.00C$ -1.66MC$ -129.00KC$ -503.00KC$ -150.00K
Operating IncomeC$ -1.52MC$ -3.95MC$ -3.35MC$ -1.39MC$ -1.17M
EBITDAC$ -1.29MC$ -75.40KC$ -335.99KC$ -101.90KC$ -76.62K
Net IncomeC$ -1.55MC$ -3.92MC$ -3.33MC$ -1.41MC$ -1.17M
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.10KC$ 2.97KC$ 831.27KC$ 506.35KC$ 448.24K
Total AssetsC$ 104.53KC$ 935.62KC$ 1.17MC$ 621.64KC$ 2.67M
Total DebtC$ 2.84MC$ 2.77MC$ 5.02MC$ 4.41MC$ 5.16M
Net DebtC$ 2.84MC$ 2.77MC$ 4.18MC$ 3.91MC$ 4.72M
Total LiabilitiesC$ 3.99MC$ 5.28MC$ 6.68MC$ 5.09MC$ 6.55M
Stockholders' EquityC$ -3.88MC$ -4.35MC$ -5.51MC$ -4.47MC$ -3.88M
Cash Flow
Free Cash FlowC$ -1.58MC$ -2.33MC$ -234.08KC$ -1.08MC$ -2.98M
Operating Cash FlowC$ -1.58MC$ -2.33MC$ -234.07KC$ -1.08MC$ -2.98M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 1.58MC$ 1.50MC$ 559.00KC$ -421.37KC$ 2.78M

Currency in CAD

Arch Biopartners Earnings and Revenue History

-10M-5M05M-7500 %-5000 %-2500 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Arch Biopartners Liabilities to Assets

02.5M5M7.5M0 %1500 %3000 %4500 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Arch Biopartners Cash Flow

-4M-2M02M4M201720182019202020212022202320242025OperatingInvestingFinancing

Arch Biopartners Forecast EPS vs Actual EPS

00000Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss